If you had looked at BASF in late 2025, you would have seen a business wrestling with thin margins, regulatory pressure, and big-ticket bets on China and agricultural chemicals. Holding BASF over the past year would have returned 31.6%, including dividends. That outcome landed between bullish hopes for portfolio streamlining and bearish worries about shrinking profitability. If you were weighing an investment then, what did the evidence really suggest about taking that risk?
The useful thing about a Narrative is that the reasoning is checkable: the assumptions sit beside the argument, and together they imply an estimated Fair Value you can disagree with.
BASF is not the only name tied to this theme. Zero in on 33 best rare earth metal stocks and compare how each one is priced.
The shares cost €42.9 at the start of the period, and BASF sat between two very different stories about where the business might head next.
On the optimistic side, one Narrative saw portfolio streamlining and asset sales setting up a cleaner BASF with a Fair Value of €49.92. That view leaned on assumptions that cost savings, the China Verbund project and an eventual Agricultural Solutions IPO could lift margins.
The more cautious Narrative put Fair Value at €39. It focused on rising decarbonization and compliance costs, pressure on demand for traditional plastics, and the risk that large investments in China might under-earn their plans.
The Zhanjiang Verbund site starting operations on schedule and below budget backed the optimistic BASF story around China and capital discipline. Q3 2026 results told a different tale. Revenue and absolute profit were higher than Q3 2025, yet net margin edged down from 1.0% to 0.9%. Taken together, the evidence cut both ways.
The hinge assumption here was margin recovery, not just higher sales. When you look at another stock built on a similar thesis, track whether revenue and net margin move together in reported results or start to diverge.
Today BASF trades at €54.28, with this cautious Narrative’s Fair Value sitting below that level even after a 31.6% gain over the past year. The bearish analyst Narrative on Simply Wall St centers on whether recent earnings strength and portfolio moves truly convert into lasting cash generation.
For today’s valuation to hold, a buyer needs to believe that cost savings, asset reshaping and projects like Zhanjiang can offset cash outflows and support future free cash flow despite current working capital and transformation charges.
"Despite BASF reporting higher EBITDA before special items and raising its 2026 EBITDA guidance range, free cash flow in Q2 2026 moved to a loss of €189m with working capital build and about €200m of transformation cash outflows, which points to a risk that ongoing cost programs and earnings guidance do not translate into the expected improvement in free cash flow and net debt reduction."
Not everyone reads the same price the same way. → See the lower figure this Narrative lands on, and how it gets there
BASF keeps you close to chemicals, regulation and energy transition spending. You could also look one step sideways.
Electrification and urbanisation need more than plastics and crop inputs. They lean on reliable supplies of copper, aluminium and lithium.
Another large producer focuses on pulling those materials out of the ground and processing them for industrial buyers worldwide.
Its projects aim to lift productivity, shift more output toward these metals and free cash from older assets.
If that shift works, the mix between traditional ore and battery materials could matter as much as any single BASF decision.
The case is on the record, with the assumptions it rests on. → See the Narrative that values this company 20% above its price
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com